The rise of the longevity economy—estimated at $10 trillion—is being propelled by demographic shifts and transformative innovations in AI, geroscience, and age-friendly technologies. With the global population over 65 projected to double by 2050, demand is growing for solutions that extend not just lifespan but healthspan. AI is central to this transformation, powering tools that enhance healthcare efficiency, personalize retirement planning, and optimize patient care. Startups like Hippocratic AI are at the forefront, using generative AI to streamline healthcare workflows and improve chronic disease management. These efforts are part of a broader trend where AI-enabled digital health startups have captured 62% of 2025’s VC investment in the space, reflecting their ability to drive both operational and patient-centric innovations.
Geroscience is also gaining traction, targeting the biological mechanisms of aging to prevent age-related diseases, while age-friendly technologies are enabling older adults to remain independent and economically active. Companies are integrating AI into smart devices, wellness programs, and flexible work platforms tailored to the aging workforce. Strategic investment opportunities abound—from AI-first healthcare platforms like Hippocratic AI and Innovaccer to geroscience and AgeTech infrastructure. However, investors must be mindful of ethical, regulatory, and equity considerations. Ultimately, the longevity economy represents not just a financial opportunity, but a societal mandate to build healthier, more inclusive futures as aging becomes a global norm.